Overview

Effects of Integrated Treatment of Traditional Medicine and Western Medicine for Sepsis-induced Cardiac Injury

Status:
Not yet recruiting
Trial end date:
2022-12-01
Target enrollment:
100
Participant gender:
All
Summary
The aim of this prospective randomized controlled clinical trial will evaluate the safety and effectiveness of Shenfu injection combined with Neiguan acupoint stimulation for sepsis-induced cardiac injury, and it is expected to provide a new combination of traditional Chinese and Western medicine treatment for sepsis-induced cardiac injury.
Phase:
Phase 2/Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Criteria
Inclusion Criteria:

- SOFA≥2 with organ dysfunction

- Age > 18 years

- cTnI＞0.03 ng/ml with/or LVEF≤50%

Exclusion Criteria:

- Patients who will undergo immediate PCI Pregnant

- Lactating women

- Patients with mental disorders

- Patients are using other experimental drugs; Refusal to provide informed.